Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study

被引：0
|
作者：
Mahmoud H. Teaima
Adi Al-Nuseirat
Dalia Abouhussein
Osama A. Badary
Mohamed A. El-Nabarawi
机构：
[1] Cairo University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
[2] World Health Organization Office for the Eastern Mediterranean Region,Access to Medicines and Health Technologies Unit
[3] Egyptian Drug Authority (EDA),Pharmaceutics Department
[4] The British University in Egypt,Department of Clinical Pharmacy Practice, Faculty of Pharmacy
来源：
Journal of Pharmaceutical Policy and Practice | / 14卷
关键词：
Pharmaceutical regulations; Direct-acting antivirals; Hepatitis C virus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] IS TREATMENT OF HEPATITIS C WITH CONTROLLED GENERIC DIRECT ACTING ANTIVIRAL DRUGS EFFECTIVE? AN EGYPTIAN EXPERIENCE
    Soliman, Gamal
    Elzalabany, Mahmoud S.
    Miller, F. DeWolfe
    Hassanein, Tarek I.
    GASTROENTEROLOGY, 2018, 154 (06) : S728 - S728
  • [42] Treatment of chronic hepatitis C (CHC) in haemophiliacs with the new direct acting antiviral drugs (DAAs)
    Ioannidou, Panagiota
    Kouramba, Anna
    Adraktas, Theophanis
    Kelaidis, Eleftherios
    Varakioti, Agoritsa
    Stauropoulou, Nikoula
    Katsarou, Olga
    HAEMOPHILIA, 2016, 22 : 62 - 63
  • [43] Impact of directly acting antiviral drugs during treatment of decompensated cirrhosis with chronic hepatitis C
    Nayak, H. K.
    Kumar, K.
    Pande, G.
    Mohindra, S.
    Saraswat, V. A.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S507 - S508
  • [44] NS5A: A new target for antiviral drugs in the treatment of hepatitis C virus infection
    Debes, Jose D.
    Smith, Coleman I.
    HEPATOLOGY, 2012, 56 (03) : 797 - 799
  • [45] New combination antiviral for the treatment of hepatitis C
    Lam, Jerika T.
    Salazar, Laura
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (14) : 1042 - 1050
  • [46] Aminoadamantanes versus other antiviral drugs for chronic hepatitis C
    Lamers, Mieke H.
    Broekman, Mark
    Drenth, Joost P. H.
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06):
  • [47] Hepatitis C antiviral treatment in special populations
    Helen S. Yee
    Teresa L. Wright
    Current Hepatitis Reports, 2003, 2 (3) : 101 - 107
  • [48] New developments in the antiviral treatment of hepatitis C
    de Bruijne, J.
    Weegink, C. J.
    Jansen, P. L. M.
    Reesink, H. W.
    VOX SANGUINIS, 2009, 97 (01) : 1 - 12
  • [49] Summary: Antiviral treatment of hepatitis c virus
    Dusheiko, GM
    ANTIVIRAL RESEARCH, 1996, 29 (01) : 77 - 82
  • [50] Tailoring the length of antiviral treatment for hepatitis C
    Mangia, Alessandra
    Andriulli, Angelo
    GUT, 2010, 59 (01) : 1 - 5
12345